Literature DB >> 7780655

Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.

F M Cutrer1, D Schoenfeld, V Limmroth, N Panahian, M A Moskowitz.   

Abstract

1. The effects of an intravenously administered sumatriptan analogue were examined on c-fos-like immunoreactivity (c-fos-LI), a marker of neuronal activation, evoked within trigeminal nucleus caudalis (TNC) and other brain stem regions 2 h after intracisternal injection of the irritant, capsaicin (0.1 ml, 0.1 mM), in pentobarbitone-anaesthetized Hartley guinea-pigs. 2. C-fos-LI was assessed in eighteen serial sections (50 microns) using a polyclonal antiserum. A weighted average, reflecting total expression within lamina I, IIo of TNC was obtained from three representative levels (i.e., at -0.225 mm, -2.475 mm and -6.975 mm.). 3. Capsaicin caused significant labelling within lamina I, IIo, a region containing axonal terminations of small unmyelinated C-fibres, as well as within the nucleus of the solitary tract, area postrema and medial reticular nucleus. A similar distribution of positive cells was reported previously after intracisternal injection of other chemical irritants such as autologous blood or carrageenin. 4. Pretreatment with a conformationally restricted sumatriptan analogue (with some selectivity for 5-HT1B and 5-HTID receptor subtypes) CP-122,288, reduced the weighted average by approximately 50-60% (P < 0.05) in lamina I, IIo at > or = 100 pmol kg-1, i.v., but did not decrease cell number within area postrema, nucleus of the solitary tract or medial reticular nucleus. A similar pattern was reported previously following sumatriptan, dihydroergotamine or CP-93,129 administration after noxious meningeal stimulation. 5. We conclude that modifications at the amino-ethyl side chain of sumatriptan dramatically enhance the suppression of c-fos expression within TNC, a finding consistent with its remarkable potency against neurogenic plasma protein extravasation within dura mater. CP-122,288 and related analogues may serve as an important prototype for drug development in migraine and related headaches.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780655      PMCID: PMC1510330          DOI: 10.1111/j.1476-5381.1995.tb13302.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Cerebral blood flow changes in migraine: methods, observations and hypotheses.

Authors:  L Friberg
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

2.  Transcranial Doppler in spontaneous attacks of migraine.

Authors:  E M Zanette; A Agnoli; C Roberti; F Chiarotti; R Cerbo; C Fieschi
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

3.  Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress.

Authors:  S Ceccatelli; M J Villar; M Goldstein; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Opiates modify induction of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation.

Authors:  T R Tölle; J M Castro-Lopes; A Coimbra; W Zieglgänsberger
Journal:  Neurosci Lett       Date:  1990-03-26       Impact factor: 3.046

5.  Blood flow velocities in the vertebrobasilar system during migraine attacks--a transcranial Doppler study.

Authors:  C P Zwetsloot; J F Caekebeke; J C Jansen; J Odink; M D Ferrari
Journal:  Cephalalgia       Date:  1992-02       Impact factor: 6.292

6.  Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation.

Authors:  D Menétrey; A Gannon; J D Levine; A I Basbaum
Journal:  J Comp Neurol       Date:  1989-07-08       Impact factor: 3.215

7.  The immediate-early genes c-fos and c-jun are differentially expressed in the rat adrenal gland after capsaicin treatment.

Authors:  M Pelto-Huikko; A Dagerlind; S Ceccatelli; T Hökfelt
Journal:  Neurosci Lett       Date:  1991-05-27       Impact factor: 3.046

8.  CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.

Authors:  K Nozaki; M A Moskowitz; P Boccalini
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

9.  Focal ischemia in rats causes time-dependent expression of c-fos protein immunoreactivity in widespread regions of ipsilateral cortex.

Authors:  Y Uemura; N W Kowall; M A Moskowitz
Journal:  Brain Res       Date:  1991-06-21       Impact factor: 3.252

10.  Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space.

Authors:  K Nozaki; P Boccalini; M A Moskowitz
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  8 in total

1.  [Animal models and their results in relation to the therapy of migraine].

Authors:  H Kaube; V Limmroth
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

2.  Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.

Authors:  X J Yu; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.

Authors:  F M Cutrer; V Limmroth; G Ayata; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors.

Authors:  Esther Martínez-García; Marcello Leopoldo; Enza Lacivita; José A Terrón
Journal:  Headache       Date:  2011 Nov-Dec       Impact factor: 5.887

Review 5.  Preclinical neuropharmacology of naratriptan.

Authors:  Geoffrey A Lambert
Journal:  CNS Drug Rev       Date:  2005

6.  The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.

Authors:  P Gupta; D Brown; P Butler; P Ellis; K L Grayson; G C Land; J E Macor; S F Robson; M J Wythes; N B Shepperson
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  The α6 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation.

Authors:  Pi-Chuan Fan; Tzu-Hsuan Lai; Chia Chun Hor; Ming Tatt Lee; Pokai Huang; Werner Sieghart; Margot Ernst; Daniel E Knutson; James Cook; Lih-Chu Chiou
Journal:  Neuropharmacology       Date:  2018-07-21       Impact factor: 5.250

8.  Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats.

Authors:  Pokai Huang; Ping-Hung Kuo; Ming Tatt Lee; Lih-Chu Chiou; Pi-Chuan Fan
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.